All News

Found 16,880 articles

• Anadys Pharmaceuticals, Inc. To Present At Lazard Capital Markets Annual Life Sciences Conference

  11/23/2005

• FDA Wants Stronger Asthma Drug Warnings On GlaxoSmithKline's Advair, Serevent And Novartis Pharma AG's Foradil

  11/21/2005

• The Day In Review: FDA News And A Big Drug Deal

  11/21/2005

• Dr. Robert Bast Joins Tanox, Inc. Scientific Advisory Board

  11/21/2005

• Cita NeuroPharmaceuticals Inc. Accepts Offer By UK-Based Vernalis PLC; For Up To $64.5 Million

  11/18/2005

• FDA Panel Rejects Novartis Corporation Transplant Drug; Advisory Committee Recommends Additional Study Data To Support Approval Of Certican(R) In Heart Transplant Recipients

  11/17/2005

• Novartis Ophthalmics AG Recalls Seven Lots Of GenTeal(R) Products In The US

  11/17/2005

• Novartis Nutrition Corporation Inc. Issues Nationwide Recall Of One Lot Of Its Diabetisource(R) AC Product

  11/17/2005

• The Day In Review: Does Tamiflu Cause Serious Side Effects?

  11/17/2005

• Labopharm's Once-Daily Tramadol Product Launched In Germany

  11/17/2005

• Myogen Files Shelf Registration Statement

  11/17/2005

• Speedel Pharmaceuticals, Inc. Release: Aliskiren, The First Effective Oral Renin Inhibitor, Provides Sustained 24 Hour Blood Pressure Control In Combination With Angiotensin Receptor Blocker

  11/16/2005

• Novartis Pharmaceuticals Corporation Release: NAVIGATOR Data Presented At American Heart Association's Scientific Sessions Provide New Insights About Cardiovascular And Diabetes Risk

  11/16/2005

• Speedel Pharmaceuticals, Inc. Announces Financial Results For First Nine Months 2005

  11/16/2005

• Novartis Corporation Transplant Drug Study Lacking

  11/15/2005

• FDA Rebuffs Novartis Pharma AG Over Delay To Biogeneric Drug

  11/15/2005

• Anadys Pharmaceuticals, Inc. To Be Added To The NASDAQ Biotechnology Index (NBI)

  11/15/2005

• Idenix Pharmaceuticals, Inc. Release: GLOBE Study Demonstrates Telbivudine Provides Significantly Greater Response On Antiviral Measures Vs. Lamivudine In Patients With Chronic Hepatitis B, The 10th Leading Cause Of Death Worldwide

  11/14/2005

• Speedel Group Release: SPP301 Phase IIb Results In Diabetic Nephropathy Presented At ASN

  11/14/2005

• Anadys Pharmaceuticals, Inc. Release: ANA975 Phase I Clinical Data To Be Presented At The American Association for Study of Liver Diseases Annual Meeting

  11/14/2005